Jackson Square Partners, LLC Sight Sciences, Inc. Transaction History

Jackson Square Partners, LLC

$258 Million
Q2 2025

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$3.36 - $6.18 $2.31 Million - $4.25 Million	-687,062 Reduced 74.84%	230,997 $840,000
Q3 2024 Nov 13, 2024	SELL	$5.49 - $8.31 $2.78 Million - $4.21 Million	-506,933 Reduced 35.57%	918,059 $5.78 Million
Q2 2024 Aug 13, 2024	SELL	$5.13 - $7.15 $948,690 - $1.32 Million	-184,930 Reduced 11.49%	1,424,992 $9.5 Million
Q1 2024 May 08, 2024	SELL	$4.02 - $5.89 $79,692 - $116,763	-19,824 Reduced 1.22%	1,609,922 $8.5 Million
Q4 2023 Feb 08, 2024	BUY	$1.29 - $5.86 $225,410 - $1.02 Million	174,737 Added 12.01%	1,629,746 $8.41 Million
Q3 2023 Nov 13, 2023	SELL	$2.88 - $8.8 $752,241 - $2.3 Million	-261,195 Reduced 15.22%	1,455,009 $4.9 Million
Q2 2023 Aug 11, 2023	BUY	$7.46 - $10.67 $3.26 Million - $4.66 Million	437,143 Added 34.18%	1,716,204 $14.2 Million
Q1 2023 May 11, 2023	BUY	$8.44 - $13.35 $585,373 - $925,915	69,357 Added 5.73%	1,279,061 $11.2 Million
Q4 2022 Feb 09, 2023	BUY	$5.58 - $13.94 $2.04 Million - $5.1 Million	366,093 Added 43.4%	1,209,704 $14.8 Million
Q3 2022 Nov 14, 2022	BUY	$6.1 - $11.41 $1.52 Million - $2.84 Million	248,560 Added 41.77%	843,611 $5.36 Million
Q2 2022 Aug 12, 2022	BUY	$6.61 - $11.99 $864,389 - $1.57 Million	130,770 Added 28.17%	595,051 $5.35 Million
Q1 2022 May 13, 2022	SELL	$11.56 - $17.9 $1.52 Million - $2.35 Million	-131,443 Reduced 22.06%	464,281 $5.37 Million
Q4 2021 Feb 14, 2022	BUY	$17.36 - $27.36 $4.43 Million - $6.99 Million	255,405 Added 75.05%	595,724 $10.5 Million
Q3 2021 Nov 12, 2021	BUY	$22.34 - $39.1 $7.6 Million - $13.3 Million	340,319 New	340,319 $7.73 Million

Others Institutions Holding SGHT

# of Institutions

Shares Held

21M

Call Options Held

Put Options Held

12.7K

View Full List

About Sight Sciences, Inc.

Ticker SGHT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,826,200
Market Cap $203M
Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...

More about SGHT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Square Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Square Partners, LLC with notifications on news.

Account